Kenvue Met RFK Jr. in Bid to Keep Tylenol Off Autism List

Tylenol-maker Kenvue Inc. spoke with Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller off a list of autism-causing treatments.

The conversation, disclosed by the company, follows reports that Kennedy plans to link pregnant women’s use of acetaminophen, which is the active ingredient in Tylenol, to autism in their children. That publication is expected later this month.